NCT06410144 Chronic Kidney Disease-Education (CKD-EDU)
| NCT ID | NCT06410144 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rochester |
| Condition | Chronic Kidney Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 326 participants |
| Start Date | 2025-02-27 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 326 participants in total. It began in 2025-02-27 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators are conducting a study to see which program better helps older patients with kidney disease choose their treatment. Investigators are also investigating if either program can reduce the number of hospital or emergency room visits in the first 6 months of the study, as well as potentially improve end-of-life care for older adults. Half of the participants will receive Program A, while the other half will receive Program B. Investigators will compare the two groups to see which participants feel better prepared about their kidney therapy decisions, experience improved end-of-life care, and have fewer emergency room visits and hospital admissions. Participants in Program A will receive information from the National Kidney Foundation and meet with a kidney therapy educator. Participants in Program B will get information about kidney disease treatment and meet with a decision-support specialist who's an expert in decision-making.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 75 years old * Has advanced kidney disease with kidney function less than 30% * Speaks English * Has not yet made a dialysis decision Exclusion Criteria: * Has already decided on dialysis or active medical care without dialysis. * Has already been seen by a Palliative Care (PC) clinician for kidney-related issues or is enrolled in hospice * Currently on dialysis * Unable to provide informed consent or complete verbally administered surveys due to health, sensory, or cognitive impairment.
Contact & Investigator
Fahad Saeed, MBBS, MSCI
PRINCIPAL INVESTIGATOR
University of Rochester
Frequently Asked Questions
Who can join the NCT06410144 clinical trial?
This trial is open to participants of all sexes, aged 75 Years or older, studying Chronic Kidney Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06410144 currently recruiting?
Yes, NCT06410144 is actively recruiting participants. Contact the research team at KidneyEducation@urmc.rochester.edu for enrollment information.
Where is the NCT06410144 trial being conducted?
This trial is being conducted at Brockport, United States, Canandaigua, United States, Hornell, United States, Rochester, United States and 1 additional location.
Who is sponsoring the NCT06410144 clinical trial?
NCT06410144 is sponsored by University of Rochester. The principal investigator is Fahad Saeed, MBBS, MSCI at University of Rochester. The trial plans to enroll 326 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.